<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Progress Notes</a></li><li><a href="#id10">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>eov with labs</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Vitamin D 1000 UNIT</td><td ID="instruction1">1 tablet Orally Once a day</td><td ID="medication1notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Active</td></tr><tr><td ID="medication2">metFORMIN HCl 850 MG</td><td ID="instruction2">TAKE 1 TABLET TWICE DAILY WITH MEALS Orally as directed for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Vitamin C 1000 MG</td><td ID="instruction3">1 tablet Orally Once a day</td><td ID="medication3notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Active</td></tr><tr><td ID="medication4">Bisoprolol Fumarate 10 MG</td><td ID="instruction4">TAKE 1 TABLET EVERY DAY Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Folic Acid 800 MCG</td><td ID="instruction5">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Amoxicillin-Pot Clavulanate 875-125 MG</td><td ID="instruction6">1 tablet Orally every 12 hrs for 5 days</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication7">metFORMIN HCl 850 MG</td><td ID="instruction7">TAKE 1 TABLET TWICE DAILY WITH MEALS Orally as directed for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Aspir-Low 81 MG</td><td ID="instruction8">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Bisoprolol Fumarate 10 MG</td><td ID="instruction9">TAKE 1 TABLET EVERY DAY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Gemfibrozil 600 MG</td><td ID="instruction10">TAKE 1 TABLET TWICE DAILY 30 MINUTES BEFORE MORNING AND EVENING MEALS Orally Twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">tiZANidine HCl 4 MG</td><td ID="instruction11">1 tablet as needed Orally BID PRN</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">hydroCHLOROthiazide 25 MG</td><td ID="instruction12">take 1 tablet Orally every morning for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication13">Rosuvastatin Calcium 40 MG</td><td ID="instruction13">TAKE 1 TABLET EVERY DAY Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication14">Zinc 10 MG</td><td ID="instruction14">1 tablet Orally Once a day</td><td ID="medication14notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Active</td></tr><tr><td ID="medication15">Benzonatate 200 MG</td><td ID="instruction15">1 capsule Orally Three times a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication16">Doxazosin Mesylate 8 MG</td><td ID="instruction16">take 1 tablet by mouth Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.6 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>101 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>70 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Heart Rate</th><td>70 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Height</th><td>71 in</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Weight</th><td>291 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital8">BMI</th><td>40.58 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital9">Oximetry</th><td>96 %</td><td>[REDACTED]</td></tr><tr><th ID="vital10">Weight-kg</th><td>132 kg</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Tampa [REDACTED] Ave</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin E11.65 ; Type 2 diabetes mellitus with other specified complication E11.69 ; Hypertensive heart disease with heart failure I11.0 ; CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min N18.2 ; Mixed hyperlipidemia E78.2 ; Benign prostatic hyperplasia with lower urinary tract symptoms N40.1 ; RENAL CYST, LEFT N28.1 ; Hypoventilation R06.89 ; Thrombocytopenia D69.6 ; Peripheral edema R60.9 ; CPAP (continuous positive airway pressure) dependence Z99.89 ; Chronic combined systolic and diastolic congestive heart failure I50.42 ; AGE-RELATED NUCLEAR CATARACT OF LEFT EYE H25.12 ; Morbid obesity E66.01 ; Non-seasonal allergic rhinitis, unspecified trigger J30.89 ; Obstructive apnea G47.33 ; BMI 40.0-44.9, adult Z68.41 ; Muscle spasm M62.838 and Atrial fibrillation, unspecified type I48.91</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin (ICD-10 - E11.65)</td><td/><td>Dietary counseling given</td><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication (ICD-10 - E11.69)</td><td/><td>Continue current therapy</td><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Hypertensive heart disease with heart failure (ICD-10 - I11.0)</td><td/><td>Continue current therapy</td><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min (ICD-10 - N18.2)</td><td>GFR 89</td><td>Monitor for changes</td><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td>Continue current therapy</td><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Benign prostatic hyperplasia with lower urinary tract symptoms (ICD-10 - N40.1)</td><td/><td>Monitor for changes</td><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>RENAL CYST, LEFT (ICD-10 - N28.1)</td><td>from abd ct scan done : [REDACTED]</td><td>Monitor for changes</td><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Hypoventilation (ICD-10 - R06.89)</td><td>from pneumology notes 11/2020</td><td>Monitor for changes</td><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Thrombocytopenia (ICD-10 - D69.6)</td><td/><td>Continue current therapy</td><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Peripheral edema (ICD-10 - R60.9)</td><td/><td>Monitor for changes</td><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>CPAP (continuous positive airway pressure) dependence (ICD-10 - Z99.89)</td><td>Pulmonary sleep Tampa Bay notes [REDACTED]</td><td>Monitor for changes</td><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Chronic combined systolic and diastolic congestive heart failure (ICD-10 - I50.42)</td><td/><td>Cardiology follow up</td><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>AGE-RELATED NUCLEAR CATARACT OF LEFT EYE (ICD-10 - H25.12)</td><td/><td>Monitor for changes</td><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Morbid obesity (ICD-10 - E66.01)</td><td/><td>Diet and exercise reviewed with patient</td><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>Non-seasonal allergic rhinitis, unspecified trigger (ICD-10 - J30.89)</td><td>from pneumology notes 11/2020</td><td>Continue current therapy</td><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Obstructive apnea (ICD-10 - G47.33)</td><td/><td>Continue current therapy</td><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>BMI 40.0-44.9, adult (ICD-10 - Z68.41)</td><td/><td><p>Walk 30 minutes 5 days each week. </p><p>Verbalize an understanding of the relationship between weight loss, weight control, and exercise.</p></td><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Muscle spasm (ICD-10 - M62.838)</td><td/><td>Continue current therapy</td><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Atrial fibrillation, unspecified type (ICD-10 - I48.91)</td><td/><td>Cardiology follow up</td><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Vitamin D 1000 UNIT</td><td>1 tablet Orally Once a day</td><td/><td/><td>*Pick strength-form from Medispan for eRX*</td></tr><tr><td ID="potMeds2">metFORMIN HCl 850 MG</td><td>TAKE 1 TABLET TWICE DAILY WITH MEALS Orally as directed for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds3">Vitamin C 1000 MG</td><td>1 tablet Orally Once a day</td><td/><td/><td>*Pick strength-form from Medispan for eRX*</td></tr><tr><td ID="potMeds4">Bisoprolol Fumarate 10 MG</td><td>TAKE 1 TABLET EVERY DAY Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds5">Folic Acid 800 MCG</td><td>1 tablet Orally Once a day</td><td/><td/><td/></tr><tr><td ID="potMeds6">Aspir-Low 81 MG</td><td>1 tablet Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds7">Gemfibrozil 600 MG</td><td>TAKE 1 TABLET TWICE DAILY 30 MINUTES BEFORE MORNING AND EVENING MEALS Orally Twice a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds8">tiZANidine HCl 4 MG</td><td>1 tablet as needed Orally BID PRN</td><td/><td/><td/></tr><tr><td ID="potMeds9">hydroCHLOROthiazide 25 MG</td><td>take 1 tablet Orally every morning for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds10">Rosuvastatin Calcium 40 MG</td><td>TAKE 1 TABLET EVERY DAY Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds11">Zinc 10 MG</td><td>1 tablet Orally Once a day</td><td/><td/><td>*Pick strength-form from Medispan for eRX*</td></tr><tr><td ID="potMeds12">Benzonatate 200 MG</td><td>1 capsule Orally Three times a day</td><td/><td/><td/></tr><tr><td ID="potMeds13">Doxazosin Mesylate 8 MG</td><td>take 1 tablet by mouth Once a day for 90 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin</td><td>Dietary counseling given</td></tr><tr><td ID="instructionpot2">Type 2 diabetes mellitus with other specified complication</td><td>Continue current therapy</td></tr><tr><td ID="instructionpot3">Hypertensive heart disease with heart failure</td><td>Continue current therapy</td></tr><tr><td ID="instructionpot4">CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min</td><td>Monitor for changes</td></tr><tr><td ID="instructionpot5">Mixed hyperlipidemia</td><td>Continue current therapy</td></tr><tr><td ID="instructionpot6">Benign prostatic hyperplasia with lower urinary tract symptoms</td><td>Monitor for changes</td></tr><tr><td ID="instructionpot7">RENAL CYST, LEFT</td><td>Monitor for changes</td></tr><tr><td ID="instructionpot8">Hypoventilation</td><td>Monitor for changes</td></tr><tr><td ID="instructionpot9">Thrombocytopenia</td><td>Continue current therapy</td></tr><tr><td ID="instructionpot10">Peripheral edema</td><td>Monitor for changes</td></tr><tr><td ID="instructionpot11">CPAP (continuous positive airway pressure) dependence</td><td>Monitor for changes</td></tr><tr><td ID="instructionpot12">Chronic combined systolic and diastolic congestive heart failure</td><td>Cardiology follow up</td></tr><tr><td ID="instructionpot13">AGE-RELATED NUCLEAR CATARACT OF LEFT EYE</td><td>Monitor for changes</td></tr><tr><td ID="instructionpot14">Morbid obesity</td><td>Diet and exercise reviewed with patient</td></tr><tr><td ID="instructionpot15">Non-seasonal allergic rhinitis, unspecified trigger</td><td>Continue current therapy</td></tr><tr><td ID="instructionpot16">Obstructive apnea</td><td>Continue current therapy</td></tr><tr><td ID="instructionpot17">BMI 40.0-44.9, adult</td><td><p>Walk 30 minutes 5 days each week. </p><p>Verbalize an understanding of the relationship between weight loss, weight control, and exercise.</p></td></tr><tr><td ID="instructionpot18">Muscle spasm</td><td>Continue current therapy</td></tr><tr><td ID="instructionpot19">Atrial fibrillation, unspecified type</td><td>Cardiology follow up</td></tr></tbody></table><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">CBC With Differential/Platelet-005009</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest2">TSH+Free T4-224576</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest3">Lipid Panel-303756</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest4">PSA Total (Reflex To Free)-480772</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest5">CMP14+eGFR-334943</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 3 Months,on Regular Scheduled OV, Reason: Follow-up of chronic conditions</td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 09:30:00 AM, [REDACTED][REDACTED]-3400, [REDACTED]</td></tr><tr><td ID="futureAppt2">Provider Name:[REDACTED], [REDACTED] 09:30:00 AM, [REDACTED][REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 251693 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>251693</td><td align="right"><span class="bold">Provider: </span>Jobse [REDACTED], MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>68 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED]-33625-4114</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   Eov with labs</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">[REDACTED]</span>: <br/>       <content>Pt visit to the office for EOV <br/>Hyperlipidemia on low fat diet <br/>BPH controlled <br/>A-fib trans esophagic echo + cardioversion<br/>Obesity diet and exercise advised <br/>CHF controlled <br/>Cataract Right side 30 days surgery done<br/>Peripheral edema controlled <br/>Patients medication have been reviewed and does not report any side effects The following Labs were reviewed and documented in chart., Patient current medication were reviewed and Refills given as in chart., Patient does not complain of any shortness of breath or chest pain.</content></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General / Constitutional</span>: <br/>      Chills denies. Fever denies.   <br/>   <span class="Underline">Allergy / Immunology</span>: <br/>      - denies lymphadenopathy.   <br/>   <span class="Underline">ENT</span>: <br/>      Runny nose denies. - denies change in vision, denies redness, denies drainage. Nasal congestion denies. Sore throat denies.   <br/>   <span class="Underline">Endocrine</span>: <br/>      Patient denies fatigue. Excessive thirst denies. Frequent urination denies. Excessive urination denies.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Cough denies<br/>. Shortness of breath denies. Wheezing denies.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Chest pain denies. Orthopnea denies. Palpitations denies<br/>. Edema denies.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Abdominal pain denies. Blood in stool denies. Change in bowel habits denies. Nausea denies. Vomiting denies.   <br/>   <span class="Underline">Hematology</span>: <br/>      Easy bleeding denies. Easy bruising denies.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Blood in the urine denies. Frequent urination denies. Painful urination denies.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Back pain denies. Muscle aches denies. Painful joints denies. Swollen joints denies.   <br/>   <span class="Underline">Peripheral Vascular</span>: <br/>      Decreased sensation in extremities denies. Painful extremities denies. Claudication denies.   <br/>   <span class="Underline">Skin</span>: <br/>      - denies rash or new skin lesions. Rash denies. Skin lesion(s) denies.   <br/>   <span class="Underline">Neurologic</span>: <br/>      Headache denies. Memory loss denies. Seizures denies. Tremor denies.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Patient denies hallucinations. - normal mood. Suicidal thoughts denies.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> Cataract LT eye 2000</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> Flu SJH 2020</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased [REDACTED] yrs,  diagnosed with Essential hypertension. Spouse: alive,  diagnosed with Essential hypertension. 1 brother(s) . 1 son(s) , 1 daughter(s) . . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Migrated Social History:</span> <br/>       Miscellaneous: (Caffeine:):1-2 cups per day(Children:):none, aware of safety issues(Community involvements:):none(Domestic violence:):none(Exercise:):occasional(Home smoke detector use:):smoke detectors(Housing:):renting(Legal problems:):none(Living with:):spouse, family(Marital status:):married(Natural support system:):relies on family, relies on government assistance(Working):Disabled, retired. <br/>      Tobacco Use: (Tobacco Use/Smoking):Are you a: nonsmoker. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingAspir-Low 81 MG Tablet Delayed Release 1 tablet Orally Once a day Bisoprolol Fumarate 10 MG Tablet TAKE 1 TABLET EVERY DAY   Doxazosin Mesylate 8 MG Tablet take 1 tablet by mouth Once a day Folic Acid 800 MCG Tablet 1 tablet Orally Once a day Gemfibrozil 600 MG Tablet TAKE 1 TABLET TWICE DAILY 30 MINUTES BEFORE MORNING AND EVENING MEALS Orally Twice a day hydroCHLOROthiazide 25 MG Tablet take 1 tablet Orally every morning metFORMIN HCl 850 MG Tablet TAKE 1 TABLET TWICE DAILY WITH MEALS Orally as directed Rosuvastatin Calcium 40 MG Tablet TAKE 1 TABLET EVERY DAY Orally Once a day tiZANidine HCl 4 MG Tablet 1 tablet as needed Orally BID PRN Vitamin C 1000 MG Tablet Chewable 1 tablet Orally Once a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Vitamin D 1000 UNIT Capsule 1 tablet Orally Once a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Zinc 10 MG Tablet 1 tablet Orally Once a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Taking Aspir-Low 81 MG Tablet Delayed Release 1 tablet Orally Once a day Taking Bisoprolol Fumarate 10 MG Tablet TAKE 1 TABLET EVERY DAY   Taking Doxazosin Mesylate 8 MG Tablet take 1 tablet by mouth Once a day Taking Folic Acid 800 MCG Tablet 1 tablet Orally Once a day Taking Gemfibrozil 600 MG Tablet TAKE 1 TABLET TWICE DAILY 30 MINUTES BEFORE MORNING AND EVENING MEALS Orally Twice a day Taking hydroCHLOROthiazide 25 MG Tablet take 1 tablet Orally every morning Taking metFORMIN HCl 850 MG Tablet TAKE 1 TABLET TWICE DAILY WITH MEALS Orally as directed Taking Rosuvastatin Calcium 40 MG Tablet TAKE 1 TABLET EVERY DAY Orally Once a day Taking tiZANidine HCl 4 MG Tablet 1 tablet as needed Orally BID PRN Taking Vitamin C 1000 MG Tablet Chewable 1 tablet Orally Once a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Taking Vitamin D 1000 UNIT Capsule 1 tablet Orally Once a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Taking Zinc 10 MG Tablet 1 tablet Orally Once a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Not-TakingAmoxicillin-Pot Clavulanate 875-125 MG Tablet 1 tablet Orally every 12 hrs Not-Taking Amoxicillin-Pot Clavulanate 875-125 MG Tablet 1 tablet Orally every 12 hrs DiscontinuedBenzonatate 200 MG Capsule 1 capsule Orally Three times a day predniSONE 10 MG Tablet 4 tabs day 1, 3 tabs day 2, 2 tabs day 3, 1 tab day 4, 1/2 a tab day 5 and 6 Orally Once a day Medication List reviewed and reconciled with the patientDiscontinued Benzonatate 200 MG Capsule 1 capsule Orally Three times a day Discontinued predniSONE 10 MG Tablet 4 tabs day 1, 3 tabs day 2, 2 tabs day 3, 1 tab day 4, 1/2 a tab day 5 and 6 Orally Once a day Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 71 in, Wt: <span class="bold">291</span> lbs, Wt-kg: 132 kg, BMI: <span class="bold">40.58</span> Index, BP: <span class="bold">101/70</span> mm Hg, HR: <span class="bold">70</span> /min, Temp: <span class="bold">97.6</span> F, RR: <span class="bold">16</span> /min, Oxygen sat %: <span class="bold">96</span> %, Body Surface Area: 2.57.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CBC With Differential/Platelet-005009</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">WBC</td><td align="left">7.5<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">7.9<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">7.0<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">6.7<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">7.6<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td></tr><tr><td align="left">RBC</td><td align="left">4.65<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.83<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.71<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.55<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.63<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td></tr><tr><td align="left">Hemoglobin</td><td align="left">13.7<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">14.0<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">13.4<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">13.2<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">13.4<br/>(Ref Range: 13.0-17.7 g/dL)</td></tr><tr><td align="left">Hematocrit</td><td align="left">39.1<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">41.9<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">40.2<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">40.7<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">39.8<br/>(Ref Range: 37.5-51.0 %)</td></tr><tr><td align="left">MCV</td><td align="left">84<br/>(Ref Range: 79-97 fL)</td><td align="left">87<br/>(Ref Range: 79-97 fL)</td><td align="left">85<br/>(Ref Range: 79-97 fL)</td><td align="left">90<br/>(Ref Range: 79-97 fL)</td><td align="left">86<br/>(Ref Range: 79-97 fL)</td></tr><tr><td align="left">MCH</td><td align="left">29.5<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">29.0<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">28.5<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">29.0<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">28.9<br/>(Ref Range: 26.6-33.0 pg)</td></tr><tr><td align="left">MCHC</td><td align="left">35.0<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">33.4<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">33.3<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">32.4<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">33.7<br/>(Ref Range: 31.5-35.7 g/dL)</td></tr><tr><td align="left">RDW</td><td align="left">13.2<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">12.8<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">13.4<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">13.3<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">13.1<br/>(Ref Range: 11.6-15.4 %)</td></tr><tr><td align="left">Platelets</td><td align="left">162<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">182<br/>(Ref Range: 150-450 x10E3/uL)</td><td class="bold" align="left">146    L<br/>(Ref Range: 150-450 x10E3/uL)</td><td class="bold" align="left">149    L<br/>(Ref Range: 150-450 x10E3/uL)</td><td class="bold" align="left">149    L<br/>(Ref Range: 150-450 x10E3/uL)</td></tr><tr><td align="left">Neutrophils</td><td align="left">53<br/>(Ref Range: Not Estab. %)</td><td align="left">53<br/>(Ref Range: Not Estab. %)</td><td align="left">64<br/>(Ref Range: Not Estab. %)</td><td align="left">68<br/>(Ref Range: Not Estab. %)</td><td align="left">57<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Lymphs</td><td align="left">33<br/>(Ref Range: Not Estab. %)</td><td align="left">33<br/>(Ref Range: Not Estab. %)</td><td align="left">25<br/>(Ref Range: Not Estab. %)</td><td align="left">21<br/>(Ref Range: Not Estab. %)</td><td align="left">29<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Monocytes</td><td align="left">8<br/>(Ref Range: Not Estab. %)</td><td align="left">7<br/>(Ref Range: Not Estab. %)</td><td align="left">8<br/>(Ref Range: Not Estab. %)</td><td align="left">7<br/>(Ref Range: Not Estab. %)</td><td align="left">8<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Eos</td><td align="left">5<br/>(Ref Range: Not Estab. %)</td><td align="left">6<br/>(Ref Range: Not Estab. %)</td><td align="left">3<br/>(Ref Range: Not Estab. %)</td><td align="left">3<br/>(Ref Range: Not Estab. %)</td><td align="left">5<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Basos</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Neutrophils (Absolute)</td><td align="left">4.0<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.2<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.4<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.5<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.3<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td></tr><tr><td align="left">Lymphs (Absolute)</td><td align="left">2.5<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">2.6<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.8<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.4<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">2.2<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td></tr><tr><td align="left">Monocytes(Absolute)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.5<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td></tr><tr><td align="left">Eos (Absolute)</td><td align="left">0.3<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td class="bold" align="left">0.5    H<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.2<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.2<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.4<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td></tr><tr><td align="left">Baso (Absolute)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td></tr><tr><td align="left">Immature Granulocytes</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Immature Grans (Abs)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td></tr><tr><td align="left">Notes:</td><td align="left">[REDACTED], Jobse [REDACTED] 09:56:58 AM EDT &gt;Reviewed</td><td align="left">[REDACTED] [REDACTED] 02:29:30 PM EDT &gt;reviewed</td><td align="left"/><td align="left">[REDACTED], Jobse [REDACTED] 11:43:47 AM &gt;reviewed</td><td align="left"/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:TSH+Free T4-224576</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">TSH</td><td align="left">1.710<br/>(Ref Range: 0.450-4.500 uIU/mL)</td><td align="left">NR<br/></td></tr><tr><td align="left">T4,Free(Direct)</td><td align="left">1.49<br/>(Ref Range: 0.82-1.77 ng/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Notes:</td><td align="left">[REDACTED], Jobse [REDACTED] 09:56:58 AM EDT &gt;Reviewed</td><td align="left"/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:Lipid Panel-303756 (Order Date - [REDACTED]) (Collection Date &amp; Time - [REDACTED])</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        Cholesterol, Total</td><td align="left">127</td><td align="left"/><td align="left">100-199 - mg/dL</td></tr><tr><td align="left">        Triglycerides</td><td align="left">147</td><td align="left"/><td align="left">0-149 - mg/dL</td></tr><tr><td align="left">        HDL Cholesterol</td><td align="left">34</td><td align="left">L</td><td align="left">&gt;39 - mg/dL</td></tr><tr><td align="left">        VLDL Cholesterol Cal</td><td align="left">26</td><td align="left"/><td align="left">5-40 - mg/dL</td></tr><tr><td align="left">        LDL Chol Calc (NIH)</td><td align="left">67</td><td align="left"/><td align="left">0-99 - mg/dL</td></tr><tr><td colspan="4"><span class="content_span">        Notes: [REDACTED], Jobse [REDACTED] 09:56:58 AM EDT &gt;Reviewed</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CMP14+eGFR-334943</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Glucose</td><td class="bold" align="left">133    H<br/>(Ref Range: 70-99 mg/dL)</td><td class="bold" align="left">139    H<br/>(Ref Range: 70-99 mg/dL)</td><td class="bold" align="left">124    H<br/>(Ref Range: 70-99 mg/dL)</td><td class="bold" align="left">121    H<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">BUN</td><td align="left">25<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">24<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">21<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">20<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Creatinine</td><td align="left">1.12<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">0.91<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">1.03<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">0.89<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">eGFR</td><td align="left">72<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">92<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">79<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">94<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">NR<br/></td></tr><tr><td align="left">BUN/Creatinine Ratio</td><td align="left">22<br/>(Ref Range: 10-24)</td><td class="bold" align="left">26    H<br/>(Ref Range: 10-24)</td><td align="left">20<br/>(Ref Range: 10-24)</td><td align="left">22<br/>(Ref Range: 10-24)</td><td align="left">NR<br/></td></tr><tr><td align="left">Sodium</td><td align="left">141<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">141<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">139<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">141<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Potassium</td><td align="left">4.1<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.6<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.2<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.8<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Chloride</td><td align="left">105<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">102<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">102<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">102<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Carbon Dioxide, Total</td><td align="left">24<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">25<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">23<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">27<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Calcium</td><td align="left">9.8<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">9.4<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">9.6<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">9.4<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Protein, Total</td><td align="left">6.8<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.5<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.8<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.8<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Albumin</td><td align="left">4.3<br/>(Ref Range: 3.9-4.9 g/dL)</td><td align="left">4.1<br/>(Ref Range: 3.9-4.9 g/dL)</td><td align="left">4.2<br/>(Ref Range: 3.9-4.9 g/dL)</td><td align="left">4.2<br/>(Ref Range: 3.9-4.9 g/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Globulin, Total</td><td align="left">2.5<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.4<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.6<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.6<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">A/G Ratio</td><td align="left">NR<br/></td><td align="left">1.7<br/>(Ref Range: 1.2-2.2)</td><td align="left">1.6<br/>(Ref Range: 1.2-2.2)</td><td align="left">1.6<br/>(Ref Range: 1.2-2.2)</td><td align="left">NR<br/></td></tr><tr><td align="left">Bilirubin, Total</td><td align="left">0.6<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.6<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.8<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.7<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Alkaline Phosphatase</td><td align="left">81<br/>(Ref Range: 44-121 IU/L)</td><td align="left">79<br/>(Ref Range: 44-121 IU/L)</td><td align="left">75<br/>(Ref Range: 44-121 IU/L)</td><td align="left">77<br/>(Ref Range: 44-121 IU/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">AST (SGOT)</td><td align="left">17<br/>(Ref Range: 0-40 IU/L)</td><td align="left">17<br/>(Ref Range: 0-40 IU/L)</td><td align="left">17<br/>(Ref Range: 0-40 IU/L)</td><td align="left">20<br/>(Ref Range: 0-40 IU/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">ALT (SGPT)</td><td align="left">18<br/>(Ref Range: 0-44 IU/L)</td><td align="left">16<br/>(Ref Range: 0-44 IU/L)</td><td align="left">19<br/>(Ref Range: 0-44 IU/L)</td><td align="left">24<br/>(Ref Range: 0-44 IU/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Notes:</td><td align="left">[REDACTED], Jobse [REDACTED] 09:56:58 AM EDT &gt;Reviewed</td><td align="left">[REDACTED] [REDACTED] 02:29:30 PM EDT &gt;reviewed</td><td align="left"/><td align="left">[REDACTED], Jobse [REDACTED] 11:43:47 AM &gt;reviewed</td><td align="left"/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: well-appearing, well-developed, no acute distress , morbidly obese. <br/>      HEENT PERRLA, EOMI, no pallor or icterus, TM's normal, no nasal congestion, Throat: no congestion or exudate. <br/>      Neck / thyroid: no JVD, no lymphadenopathy, no thyromegaly, no carotid bruit. <br/>      Heart: regular rhythm, S1S2 normal, no S3 S4, no murmur, gallop or rub. <br/>      Chest: symmetric without any chest wall tenderness. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Abdomen: soft, non tender, not distended, BS +, no organomegaly. <br/>      Neurologic: conscious, AAO x 3, no new focal deficits. <br/>      Back: no spinal deformity or tenderness, no CVA tenderness. <br/>      Musculoskeletal: no new joint swellings or deformities. <br/>      Skin: no rash or new skin lesions, normal turgor and texture. <br/>      Breasts: deferred. <br/>      Cardiovascular Peripheral vascular. <br/>      Genitourinary deferred.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin - E11.65 (Primary)   2. Type 2 diabetes mellitus with other specified complication - E11.69   <content><span class="bold">Specify : </span>Hyperlipidemia</content>   3. Hypertensive heart disease with heart failure - I11.0   <content><span class="bold">Specify : </span>CKD stage 2</content>   4. CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min - N18.2   <content><span class="bold">Notes : </span>GFR 89</content>   5. Mixed hyperlipidemia - E78.2   6. Benign prostatic hyperplasia with lower urinary tract symptoms - N40.1   7. RENAL CYST, LEFT - N28.1   <content><span class="bold">Notes : </span>from abd ct scan done : [REDACTED]</content>   8. Hypoventilation - R06.89   <content><span class="bold">Notes : </span>from pneumology notes 11/2020</content>   9. Thrombocytopenia - D69.6   10. Peripheral edema - R60.9   11. CPAP (continuous positive airway pressure) dependence - Z99.89   <content><span class="bold">Notes : </span>Pulmonary sleep Tampa Bay notes [REDACTED]</content>   12. Chronic combined systolic and diastolic congestive heart failure - I50.42   13. AGE-RELATED NUCLEAR CATARACT OF LEFT EYE - H25.12   14. Morbid obesity - E66.01   15. Non-seasonal allergic rhinitis, unspecified trigger - J30.89   <content><span class="bold">Notes : </span>from pneumology notes 11/2020</content>   16. Obstructive apnea - G47.33   17. BMI 40.0-44.9, adult - Z68.41   18. Muscle spasm - M62.838   19. Atrial fibrillation, unspecified type - I48.91   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin</span> <br/>     <span class="Underline">LAB: CBC With Differential/Platelet-005009</span><br/>     <span class="Underline">LAB: TSH+Free T4-224576</span><br/>     <span class="Underline">LAB: Lipid Panel-303756</span><br/>     <span class="Underline">LAB: PSA Total (Reflex To Free)-480772</span><br/>     <span class="Underline">LAB: CMP14+eGFR-334943</span><br/>Notes: Dietary counseling given  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Type 2 diabetes mellitus with other specified complication</span> <br/>Refill metFORMIN HCl Tablet, 850 MG, TAKE 1 TABLET TWICE DAILY WITH MEALS, Orally, as directed, 90 days, 180, Refills 0.  <br/>     <span class="Underline">LAB: CBC With Differential/Platelet-005009</span><br/>     <span class="Underline">LAB: TSH+Free T4-224576</span><br/>     <span class="Underline">LAB: Lipid Panel-303756</span><br/>     <span class="Underline">LAB: PSA Total (Reflex To Free)-480772</span><br/>     <span class="Underline">LAB: CMP14+eGFR-334943</span><br/>Notes: Continue current therapy  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Hypertensive heart disease with heart failure</span> <br/>Refill Aspir-Low Tablet Delayed Release, 81 MG, 1 tablet, Orally, Once a day, 90 days, 90 Tablet, Refills 0; Refill Doxazosin Mesylate Tablet, 8 MG, take 1 tablet, by mouth, Once a day, 90 days, 90, Refills 1; Refill hydroCHLOROthiazide Tablet, 25 MG, take 1 tablet, Orally, every morning, 90 days, 90, Refills 1.  <br/>     <span class="Underline">LAB: CBC With Differential/Platelet-005009</span><br/>     <span class="Underline">LAB: TSH+Free T4-224576</span><br/>     <span class="Underline">LAB: Lipid Panel-303756</span><br/>     <span class="Underline">LAB: PSA Total (Reflex To Free)-480772</span><br/>     <span class="Underline">LAB: CMP14+eGFR-334943</span><br/>Notes: Continue current therapy  </td></tr><tr><td/></tr><tr><td><span class="bold">4. CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min</span> <br/>     <span class="Underline">LAB: CBC With Differential/Platelet-005009</span><br/>     <span class="Underline">LAB: TSH+Free T4-224576</span><br/>     <span class="Underline">LAB: Lipid Panel-303756</span><br/>     <span class="Underline">LAB: PSA Total (Reflex To Free)-480772</span><br/>     <span class="Underline">LAB: CMP14+eGFR-334943</span><br/>Notes: Monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Mixed hyperlipidemia</span> <br/>Refill Gemfibrozil Tablet, 600 MG, TAKE 1 TABLET TWICE DAILY 30 MINUTES BEFORE MORNING AND EVENING MEALS, Orally, Twice a day, 90 days, 180, Refills 3; Refill Rosuvastatin Calcium Tablet, 40 MG, TAKE 1 TABLET EVERY DAY, Orally, Once a day, 90 days, 90, Refills 3.  <br/>Notes: Continue current therapy  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Benign prostatic hyperplasia with lower urinary tract symptoms</span> <br/>Notes: Monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">7. RENAL CYST, LEFT</span> <br/>Notes: Monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Hypoventilation</span> <br/>Notes: Monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Thrombocytopenia</span> <br/>Continue Folic Acid Tablet, 800 MCG, 1 tablet, Orally, Once a day; Continue Vitamin C Tablet Chewable, 1000 MG, 1 tablet, Orally, Once a day, Notes to Pharmacist: *Pick strength-form from Medispan for eRX*; Continue Vitamin D Capsule, 1000 UNIT, 1 tablet, Orally, Once a day, Notes to Pharmacist: *Pick strength-form from Medispan for eRX*.  <br/>Notes: Continue current therapy  </td></tr><tr><td/></tr><tr><td><span class="bold">10. Peripheral edema</span> <br/>Notes: Monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">11. CPAP (continuous positive airway pressure) dependence</span> <br/>Notes: Monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Chronic combined systolic and diastolic congestive heart failure</span> <br/>Refill Bisoprolol Fumarate Tablet, 10 MG, TAKE 1 TABLET EVERY DAY, Orally, Once a day, 90 days, 90, Refills 0.  <br/>Notes: Cardiology follow up  </td></tr><tr><td/></tr><tr><td><span class="bold">13. AGE-RELATED NUCLEAR CATARACT OF LEFT EYE</span> <br/>Notes: Monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">14. Morbid obesity</span> <br/>Notes: Diet and exercise reviewed with patient  </td></tr><tr><td/></tr><tr><td><span class="bold">15. Non-seasonal allergic rhinitis, unspecified trigger</span> <br/>Continue Zinc Tablet, 10 MG, 1 tablet, Orally, Once a day, Notes to Pharmacist: *Pick strength-form from Medispan for eRX*.  <br/>Notes: Continue current therapy  </td></tr><tr><td/></tr><tr><td><span class="bold">16. Obstructive apnea</span> <br/>Continue Benzonatate Capsule, 200 MG, 1 capsule, Orally, Three times a day.  <br/>Notes: Continue current therapy  </td></tr><tr><td/></tr><tr><td><span class="bold">17. BMI 40.0-44.9, adult</span> <br/>Notes: Walk 30 minutes 5 days each week. <br/>Verbalize an understanding of the relationship between weight loss, weight control, and exercise.  </td></tr><tr><td/></tr><tr><td><span class="bold">18. Muscle spasm</span> <br/>Continue tiZANidine HCl Tablet, 4 MG, 1 tablet as needed, Orally, BID PRN.  <br/>Notes: Continue current therapy  </td></tr><tr><td/></tr><tr><td><span class="bold">19. Atrial fibrillation, unspecified type</span> <br/>Notes: Cardiology follow up  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 3074F SYST BP LT 130 MM HG3078F DIAST BP &lt; 80 MM HGG8427 DOC MEDS VERIFIED W/PT OR REG8417 BMI &gt;=30 CALCUATE W/FOLLOWUP</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  <br/>   Counseling: Patient Education - Patient education materials given: Yes;<br/>  Body Mass Index - BMI management provided Yes;<br/>  ;<br/>  Screenings: Fall Risk Screening - Fall Risk Assessment: No falls in the past year;<br/>  ;<br/>.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 3 Months,on Regular Scheduled OV (Reason: Follow-up of chronic conditions)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>3074F SYST BP LT 130 MM HG. <br/>3078F DIAST BP &lt; 80 MM HG. <br/>G8427 DOC MEDS VERIFIED W/PT OR RE. <br/>G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP. </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , MD, ACN765  on [REDACTED] 11:51 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], MD</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 11:29 AM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="14">General Examination</td><td>General appearance:</td><td colspan="2">well-appearing, well-developed, no acute distress , morbidly obese</td></tr><tr><td>Neck / thyroid:</td><td colspan="2">no JVD, no lymphadenopathy, no thyromegaly, no carotid bruit</td></tr><tr><td>Heart:</td><td colspan="2">regular rhythm, S1S2 normal, no S3 S4, no murmur, gallop or rub</td></tr><tr><td>Chest:</td><td colspan="2">symmetric without any chest wall tenderness</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Abdomen:</td><td colspan="2">soft, non tender, not distended, BS +, no organomegaly</td></tr><tr><td>Neurologic:</td><td colspan="2">conscious, AAO x 3, no new focal deficits</td></tr><tr><td>Skin:</td><td colspan="2">no rash or new skin lesions, normal turgor and texture</td></tr><tr><td>Back:</td><td colspan="2">no spinal deformity or tenderness, no CVA tenderness</td></tr><tr><td>Breasts:</td><td colspan="2">deferred</td></tr><tr><td>Musculoskeletal:</td><td colspan="2">no new joint swellings or deformities</td></tr><tr><td>HEENT</td><td colspan="2">PERRLA, EOMI, no pallor or icterus, TM's normal, no nasal congestion, Throat: no congestion or exudate</td></tr><tr><td>Cardiovascular</td><td colspan="2">Peripheral vascular</td></tr><tr><td>Genitourinary</td><td colspan="2">deferred</td></tr></tbody></table><br/></li></ul></div><br/><br/>
</body></html>